Skip to content

Speech Processing in Stuttering

Speech Processing in Stuttering

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04929184
Enrollment
145
Registered
2021-06-18
Start date
2022-04-04
Completion date
2025-06-16
Last updated
2026-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stuttering, Stuttering, Adult, Stuttering, Childhood

Keywords

Healthy children, Healthy Adults

Brief summary

This research is being done to better understand stuttering, specifically how people who stutter may process and/or produce speech. Eligible participants enrolled will complete a variety of computer and speech-based tasks on up to 2 visits.

Detailed description

The study team will update the record to include the secondary identification number once the NIH has released the funds.

Interventions

BEHAVIORALSpeech and non-speech tasks

Participants will complete speech tasks such as listening to and/or producing speech and non-speech sounds.

Sponsors

University of Michigan
Lead SponsorOTHER
National Institute on Deafness and Other Communication Disorders (NIDCD)
CollaboratorNIH

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

(adults who do not stutter): * 18-65 years old * English as primary language * Normal speech, language, hearing, cognition

Exclusion criteria

(adults who do not stutter) * Personal or family history of stuttering * Major medical or psychiatric illness Inclusion criteria: (adults who stutter) * Aged 18-65 years * English as primary language * Normal speech, language, hearing, cognition (other than stuttering) * Currently stutters

Design outcomes

Primary

MeasureTime frameDescription
Phase Locking Value (PLV) - Session 1 Speech TasksSession 1 (up to 4 hours)Participants will hear a series of single syllables spoken rhythmically and will be instructed to whisper the syllable "tah" repeatedly while the recording is playing. The degree of synchronization (how well the participant's whispered syllables match the cadence of the recorded syllables they are listening to) will be measured by computing the PLV between subject's produced speech and the heard speech. The PLV is a vector with a value between 0 and 1 that reflects the phase difference between two signals, where 0 is a complete mis-match and a 1 is a perfect match. Adults were not instructed to attempt to match the cadence (Implicit task). Child participants were instructed to attempt to match the cadence (Explicit task).
Phase Locking Value (PLV) - Session 2 Speech TasksSession 2 (up to 4 hours)Adult participants will hear a series of single syllables spoken rhythmically and will be instructed to whisper the syllable "tah" repeatedly while the recording is playing. Child participants did not attend Session 2. The degree of synchronization (how well the participant's whispered syllables match the cadence of the recorded syllables they are listening to) will be measured by computing the PLV between subject's produced speech and the heard speech. The PLV is a vector with a value between 0 and 1 that reflects the phase difference between two signals, where 0 is a complete mis-match and a 1 is a perfect match. Adults completed this task twice. For the first test, they were not instructed to attempt to match the cadence (Implicit task). For the second test, they were instructed to attempt to match the cadence (Explicit task).

Secondary

MeasureTime frameDescription
R Statistic (Resultant Vector Length)Session 1 (up to 4 hours)In tapping synchronization (sensorimotor synchronization) research, the R statistic generally refers to the resultant vector length derived from circular statistics, used to quantify the consistency and stability of a participant's tapping relative to a rhythmic stimulus. It ranges from 0 to 1. 0=Complete inconsistency (taps are uniformly distributed). 1=Perfect consistency (all taps occur at the exact same relative phase).

Countries

United States

Contacts

PRINCIPAL_INVESTIGATOREmily Garnett, PhD

University of Michigan

Participant flow

Pre-assignment details

145 participants were enrolled (signed consent form). 26 participants were either lost to follow up (n=15; including 2 participants between Visit 1 and Visit 2) or determined to be ineligible following enrollment (n=11).

Baseline characteristics

Characteristic
Age, Continuous30.7 Years
STANDARD_DEVIATION 10.3
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
53 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
Race (NIH/OMB)
Asian
9 Participants
Race (NIH/OMB)
Black or African American
15 Participants
Race (NIH/OMB)
More than one race
2 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
32 Participants
Region of Enrollment
United States
10 participants
Sex/Gender, Customized
Female
27 Participants
Sex/Gender, Customized
Male
39 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 550 / 670 / 130 / 10
other
Total, other adverse events
0 / 550 / 670 / 130 / 10
serious
Total, serious adverse events
0 / 550 / 670 / 130 / 10

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 18, 2026